S&P 500   4,989.32 (-0.44%)
DOW   38,028.74 (+0.67%)
QQQ   416.96 (-1.52%)
AAPL   165.03 (-1.20%)
MSFT   399.52 (-1.17%)
META   484.01 (-3.55%)
GOOGL   154.03 (-1.27%)
AMZN   174.96 (-2.38%)
TSLA   149.16 (-0.51%)
NVDA   804.06 (-5.04%)
AMD   149.40 (-3.66%)
NIO   3.83 (-4.25%)
BABA   68.85 (-0.04%)
T   16.36 (+0.18%)
F   12.09 (+0.25%)
MU   107.39 (-4.06%)
GE   149.19 (-2.45%)
CGC   8.09 (+3.32%)
DIS   112.13 (-0.27%)
AMC   3.24 (+10.96%)
PFE   25.81 (+1.65%)
PYPL   62.16 (+0.10%)
XOM   120.07 (+1.31%)
S&P 500   4,989.32 (-0.44%)
DOW   38,028.74 (+0.67%)
QQQ   416.96 (-1.52%)
AAPL   165.03 (-1.20%)
MSFT   399.52 (-1.17%)
META   484.01 (-3.55%)
GOOGL   154.03 (-1.27%)
AMZN   174.96 (-2.38%)
TSLA   149.16 (-0.51%)
NVDA   804.06 (-5.04%)
AMD   149.40 (-3.66%)
NIO   3.83 (-4.25%)
BABA   68.85 (-0.04%)
T   16.36 (+0.18%)
F   12.09 (+0.25%)
MU   107.39 (-4.06%)
GE   149.19 (-2.45%)
CGC   8.09 (+3.32%)
DIS   112.13 (-0.27%)
AMC   3.24 (+10.96%)
PFE   25.81 (+1.65%)
PYPL   62.16 (+0.10%)
XOM   120.07 (+1.31%)
S&P 500   4,989.32 (-0.44%)
DOW   38,028.74 (+0.67%)
QQQ   416.96 (-1.52%)
AAPL   165.03 (-1.20%)
MSFT   399.52 (-1.17%)
META   484.01 (-3.55%)
GOOGL   154.03 (-1.27%)
AMZN   174.96 (-2.38%)
TSLA   149.16 (-0.51%)
NVDA   804.06 (-5.04%)
AMD   149.40 (-3.66%)
NIO   3.83 (-4.25%)
BABA   68.85 (-0.04%)
T   16.36 (+0.18%)
F   12.09 (+0.25%)
MU   107.39 (-4.06%)
GE   149.19 (-2.45%)
CGC   8.09 (+3.32%)
DIS   112.13 (-0.27%)
AMC   3.24 (+10.96%)
PFE   25.81 (+1.65%)
PYPL   62.16 (+0.10%)
XOM   120.07 (+1.31%)
S&P 500   4,989.32 (-0.44%)
DOW   38,028.74 (+0.67%)
QQQ   416.96 (-1.52%)
AAPL   165.03 (-1.20%)
MSFT   399.52 (-1.17%)
META   484.01 (-3.55%)
GOOGL   154.03 (-1.27%)
AMZN   174.96 (-2.38%)
TSLA   149.16 (-0.51%)
NVDA   804.06 (-5.04%)
AMD   149.40 (-3.66%)
NIO   3.83 (-4.25%)
BABA   68.85 (-0.04%)
T   16.36 (+0.18%)
F   12.09 (+0.25%)
MU   107.39 (-4.06%)
GE   149.19 (-2.45%)
CGC   8.09 (+3.32%)
DIS   112.13 (-0.27%)
AMC   3.24 (+10.96%)
PFE   25.81 (+1.65%)
PYPL   62.16 (+0.10%)
XOM   120.07 (+1.31%)
Free Trial
NASDAQ:UBIO

ProShares UltraPro Nasdaq Biotechnology (UBIO) Price, Holdings, & News

→ This company has increased its dividend every year for 54 years (From DTI) (Ad)
Free UBIO Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$17.61
▼
$17.61
50-Day Range
$17.61
▼
$17.77
52-Week Range
$13.13
▼
$35.36
Volume
N/A
Average Volume
42,922 shs
Market Capitalization
$14.97 million
Assets Under Management
$27.06 million
Dividend Yield
0.00%
Net Expense Ratio
0.95%
Stock Analysis
Stock Analysis

UBIO ETF News Headlines

December 27, 2023 | benzinga.com
Moleculin Biotech Stock (NASDAQ:MBRX) Dividends: History, Yield and Dates
November 6, 2023 | fool.com
ProShares Trust - ProShares Ultra Nasdaq Cloud Computing (NASDAQ: SKYU)
April 19, 2024 | Banyan Hill Publishing (Ad)
The Best AI Stock to Own in the World Today is Trading for Just $25
“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.
August 8, 2023 | thestreet.com
ProShares UltraPro Short Nasdaq Biotechnology
January 5, 2023 | benzinga.com
PharmaCyte Biotech Stock (NASDAQ:PMCB), Quotes and News Summary
See More Headlines
Receive UBIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ProShares UltraPro Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
ProShares
Fund Name
ProShares UltraPro NASDAQ Biotechnology
Tax Classification
Regulated Investment Company
Stock Exchange
NASDAQ
Current Symbol
NASDAQ:UBIO
Inception Date
6/22/2015
Fund Manager
Michael Neches, Tarak Dave
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
NASDAQ Biotechnology Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
0

Fund Statistics

Assets Under Management
$27.06 million
Average Daily Volume
$58,712.30
Discount/Premium
-0.04%

Administrator, Advisor and Custodian

Administrator
J.P. Morgan Investor Services Co.
Advisor
ProShare Advisors LLC
Custodian
JPMorgan Chase Bank, N.A.
Distributor
SEI Investments Distribution Co.
Transfer Agent
JPMorgan Chase Bank, N.A.
Trustee
N/A
Lead Market Maker
Virtu Financial

Miscellaneous

Outstanding Shares
850,000
Beta
N/A
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report
Ad WealthPress
The system that called 2023’s top 7 stocks is at it again…
Look 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today.
Just follow this link here!

ProShares UltraPro Nasdaq Biotechnology Expenses

TypeUBIOHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.75%0.56%0.54%0.48%0.51%
Other Expenses0.57%0.40%0.54%0.34%0.58%
Total Expense1.32%0.72%0.70%0.58%0.70%
Fee Waiver-0.37%-0.53%-0.55%-0.22%-0.57%
Net Expense0.95%0.60%0.60%0.54%0.58%

ProShares UltraPro Nasdaq Biotechnology (UBIO) Exposure

UBIO Sector Exposure

UBIO Industry Exposure

Full Holdings Details

UBIO ETF - Frequently Asked Questions

What does UBIO invest in?

ProShares UltraPro Nasdaq Biotechnology is a equity fund issued by ProShares. UBIO focuses on health care investments and follows the NASDAQ Biotechnology Index. The fund's investments total to approximately $27.06 million assets under management.

What is the management fee for ProShares UltraPro Nasdaq Biotechnology?

ProShares UltraPro Nasdaq Biotechnology's management fee is 0.75% and has other expenses of 0.57%. However, UBIO has a fee waiver of -0.37% to reimburse the expenses. The net expense ratio for UBIO is 0.95%.

What other stocks do shareholders of ProShares UltraPro Nasdaq Biotechnology own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ProShares UltraPro Nasdaq Biotechnology investors own include Shopify (SHOP), Energous (WATT), Arista Networks (ANET), Markel Group (MKL), NVIDIA (NVDA), Block (SQ), VMware (VMW), Adobe (ADBE) and Aimmune Therapeutics (AIMT).

This page (NASDAQ:UBIO) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The “Perfect Storm” for Gold
Gold Safe Exchange
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
The #1 Crypto for 2024
InvestorPlace
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
1970’s computer coder issues shocking A.I. warning
TradeSmith